---
title: "IVDR rule 2: Blood grouping and tissue typing"
url: https://normiq.app/en/classification/ivdr/rule-2
language: en
updated: 2026-11-15
---

# IVDR rule 2: Blood grouping and tissue typing

IVDR · Annex VIII, Section 2.2 · CLASSIFICATION RULES

Updated on November 15, 2026

## Official text

Devices intended to be used for blood grouping, or to determine foeto-maternal blood group incompatibility, or for tissue typing to ensure the immunological compatibility of blood, blood components, cells, tissue or organs that are intended for transfusion or transplantation or cell administration, are classified as class C, except when intended to determine any of the following markers:

- ABO system \[A (ABO1), B (ABO2), AB (ABO3)];
- Rhesus system \[RH1 (D), RHW1, RH2 (C), RH3 (E), RH4 (c), RH5 (e)];
- Kell system \[Kel1 (K)];
- Kidd system \[JK1 (Jka), JK2 (Jkb)];
- Duffy system \[FY1 (Fya), FY2 (Fyb)];

in which case they are classified as class D.

IVDR, Annex VIII, Section 2.2, consolidated version of January 10, 2025.

Short link: [normiq.app/en/ivdr/annexe/viii/2](https://normiq.app/en/ivdr/annexe/viii/2)

## In plain words

Devices for blood grouping, for determining foeto-maternal blood group incompatibility or for tissue typing to ensure immunological compatibility for transfusion, transplantation or cell administration are in class C. They are in class D when intended to determine any of the listed markers of the ABO, Rhesus, Kell, Kidd or Duffy systems.

Explanation written by Normiq; only the official text above is authoritative.

## Examples from the MDCG guidance

The guidance lists these examples under rule 2 (MDCG 2020-16 rev.5). It is not legally binding, and the class always depends on the intended purpose of the device (Annex VIII, Section 1.1).

### Class C

- Anti-Lea Monoclonal blood grouping reagent for transfusion purposes.

  MDCG 2020-16 rev.5, 4, Rule 2, p. 15

### Class D

- Pre-transfusion ABO compatibility test cards intended to be used at the recipient’s bedside as precaution against ABO-incompatible purposes.

  MDCG 2020-16 rev.5, 4, Rule 2, p. 15

- Foetal RhD typing kit.

  MDCG 2020-16 rev.5, 4, Rule 2, p. 15

## Classes and Normiq roadmaps

Rule 2 assigns: Class C, Class D. For each, the Normiq roadmap on every market where Annex VIII applies.

### Class C

- [European Union 15 phases · 63 steps · estimated duration 270 days See the roadmap →](https://normiq.app/en/roadmap/eu/ivd-class-c)
- [Switzerland 16 phases · 61 steps · estimated duration 135 days See the roadmap →](https://normiq.app/en/roadmap/switzerland/ivd-class-c)
- [European Union and Switzerland 16 phases · 66 steps · estimated duration 330 days See the roadmap →](https://normiq.app/en/roadmap/eu-switzerland/ivd-class-c)

### Class D

- [European Union 15 phases · 65 steps · estimated duration 360 days See the roadmap →](https://normiq.app/en/roadmap/eu/ivd-class-d)
- [Switzerland 16 phases · 63 steps · estimated duration 180 days See the roadmap →](https://normiq.app/en/roadmap/switzerland/ivd-class-d)
- [European Union and Switzerland 16 phases · 68 steps · estimated duration 450 days See the roadmap →](https://normiq.app/en/roadmap/eu-switzerland/ivd-class-d)

## The same rule in Switzerland

> Devices shall be divided into classes A, B, C and D, taking into account the intended purpose of the devices and their inherent risks. This classification must comply with the provisions of Annex VIII to EU-IVDR.

Fedlex’s English translation, which has no legal force: the ordinance is official only in French, German and Italian.

[Art. 14 IvDO](https://www.fedlex.admin.ch/eli/cc/2022/291/en#art_14)

## Classify your device

The tool asks the questions of the 7 rules of the IVDR, one at a time, and gives the indicative class with the rule and its text.

[Open the classification tool](https://normiq.app/en/classification#outil)

## Official sources

- [IVDR, consolidated version of January 10, 2025 (02017R0746-20250110), EUR-Lex](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:02017R0746-20250110)
- [MDCG 2020-16 rev.5, “Guidance on Classification Rules for In Vitro Diagnostic Medical Devices under Regulation (EU) 2017/746”, September 2026, p. 15](https://health.ec.europa.eu/document/download/12f9756a-1e0d-4aed-9783-d948553f1705_en?filename=md_mdcg_2020_guidance_classification_ivd-md_en.pdf)
